Agreement on Trade-Related Aspects of Intellectual Property Rights

Agreement on Trade-Related Aspects of Intellectual Property Rights is a comprehensive multilateral agreement on intellectual property administered by the World Trade Organization. It establishes minimum standards for the regulation of various forms of intellectual property by national governments and integrates intellectual property law into the international trading system for the first time. Negotiated during the Uruguay Round of the General Agreement on Tariffs and Trade, it remains one of the most consequential treaties in global economic governance.

Background and negotiation

The push for an international intellectual property framework gained momentum in the 1980s, driven largely by industries in the United States, the European Communities, and Japan that were concerned about counterfeiting and piracy. Organizations like the International Intellectual Property Alliance and the Intellectual Property Committee lobbied aggressively to place intellectual property on the trade agenda. The Uruguay Round, launched in Punta del Este in 1986, formally introduced trade-related intellectual property rights as a negotiation topic, overcoming significant resistance from developing countries such as India and Brazil. The final text was concluded as part of the Marrakesh Agreement which established the World Trade Organization.

Key provisions and standards

The agreement mandates that members adhere to the substantive obligations of key pre-existing World Intellectual Property Organization conventions, including the Paris Convention for the Protection of Industrial Property and the Berne Convention for the Protection of Literary and Artistic Works. It sets minimum standards for copyright, trademarks, geographical indications, industrial designs, patents, layout-designs of integrated circuits, and protection of undisclosed information. A critical provision requires countries to grant patents for inventions in all fields of technology, including for pharmaceutical drugs, and to provide patent terms lasting at least twenty years from the filing date.

Implementation and enforcement

Members are required to ensure that their domestic laws provide for effective enforcement procedures, including detailed rules on civil and administrative procedures, provisional measures, and border controls. The agreement specifies remedies such as injunctions, damages, and the authority for judicial authorities to order the disposal of infringing goods. It also contains specific requirements for criminal procedure and penalties in cases of willful trademark counterfeiting or copyright piracy on a commercial scale, obligating action by authorities like customs agencies.

Dispute settlement

Disputes between members concerning compliance with the agreement are subject to the integrated Dispute Settlement Understanding of the World Trade Organization. This process can involve consultations, the establishment of a panel, and potentially an appeal to the Appellate Body. Authorized retaliatory measures, or suspension of concessions, can be imposed if a member fails to bring its measures into conformity following a ruling, making it one of the few international intellectual property treaties with a strong enforcement mechanism.

Criticism and public health debates

The agreement has faced sustained criticism from civil society groups, developing countries, and public health advocates. A central controversy has been its impact on access to essential medicines, particularly during crises like the HIV/AIDS pandemic. Landmark legal battles, such as the case brought by multinational pharmaceutical companies against the government of South Africa, highlighted these tensions. This led to the Doha Declaration on the TRIPS Agreement and Public Health, which affirmed members' rights to use flexibilities like compulsory licensing to protect public health.

Subsequent developments and reviews

The agreement includes built-in agendas for further negotiation, leading to subsequent treaties like the Geneva Act of the Lisbon Agreement. The issue of extending higher protection to geographical indications for products other than wines and spirits remains unresolved. A major amendment, the Protocol Amending the TRIPS Agreement, was adopted to facilitate compulsory licensing for export to countries with insufficient manufacturing capacity, formalizing a 2003 waiver. Periodic reviews by the TRIPS Council continue to address issues such as technology transfer and the relationship between the agreement and the Convention on Biological Diversity.